XML 22 R12.htm IDEA: XBRL DOCUMENT v3.22.2
General (Detail Textuals) - USD ($)
1 Months Ended 14 Months Ended
Mar. 16, 2021
Mar. 15, 2021
Apr. 25, 2022
Apr. 30, 2021
Jun. 30, 2022
Restructuring Cost and Reserve [Line Items]          
Number of common shares for each preferred share converted 1        
Reverse stock split conversion ratio 0.04        
Market capitalization amount $ 58,700,000        
Isuuance and sale value of ADSs and warrants   $ 45,500,000      
Warrant exercise price   $ 17.35      
Warrants exercisable period   5 years      
Proceeds from exercise of warrants   $ 4,500,000      
Amount of total sale and transfer of compounds and products kestrel paid   $ 1,000,000      
American Depositary Share ("ADS") [Member] | At The Market Offering Agreement With Cantor Fitzgerald & Co. [Member]          
Restructuring Cost and Reserve [Line Items]          
Aggregate offering price       $ 75,000,000  
Shares issued under agreement         699,806
Average price of shares issued under agreement         $ 22.75
Gross proceeds from sale under agreement         $ 15,900,000
American Depositary Share ("ADS") [Member] | Maximum [Member] | At The Market Offering Agreement With Cantor Fitzgerald & Co. [Member]          
Restructuring Cost and Reserve [Line Items]          
Aggregate offering price     $ 18,125,000    
Former Chemomab Security Holders [Member]          
Restructuring Cost and Reserve [Line Items]          
Shareholding percentage immediately following the merger 90.00%        
Number of common shares for each preferred share converted 65,675,904        
Accumulated deficit $ 2,500,000        
Merger agreement with Chemomab, an Israeli limited company and a clinical-stage biotech company [Member]          
Restructuring Cost and Reserve [Line Items]          
Number of ordinary shares represented by each ADS (in shares) 20        
Number of ADS issued and outstanding after the merger 12.86        
Number of shares diluted after the merger 8,078,727        
Number of shares after merger for each share of Chemomab 9,003,357